Future studies to investigate RASAL2 expression in PCa tissues and examine relationship with clinical cancer stage as well as histological grade are warranted as RASAL2 has the potential as a novel prognostic marker and a therapeutic target for PCa and other cancers. This evidence concerns the gene RASAL2 and cancer.